LIVRQNac increases fatty acid oxidization in a primary human hepatocyte model of non-alcoholic steatohepatitis
Publication
, Conference
Russell, M; Newgard, C; Zhang, G; Nitzel, A; Hamill, M; Azer, K
Published in: JOURNAL OF HEPATOLOGY
2022
Duke Scholars
Published In
JOURNAL OF HEPATOLOGY
EISSN
1600-0641
ISSN
0168-8278
Publication Date
2022
Volume
77
Start / End Page
S718 / S718
Related Subject Headings
- Gastroenterology & Hepatology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Russell, M., Newgard, C., Zhang, G., Nitzel, A., Hamill, M., & Azer, K. (2022). LIVRQNac increases fatty acid oxidization in a primary human hepatocyte model of non-alcoholic steatohepatitis. In JOURNAL OF HEPATOLOGY (Vol. 77, pp. S718–S718).
Russell, Matthew, Christopher Newgard, Guofang Zhang, Arianna Nitzel, Michael Hamill, and Karim Azer. “LIVRQNac increases fatty acid oxidization in a primary human hepatocyte model of non-alcoholic steatohepatitis.” In JOURNAL OF HEPATOLOGY, 77:S718–S718, 2022.
Russell M, Newgard C, Zhang G, Nitzel A, Hamill M, Azer K. LIVRQNac increases fatty acid oxidization in a primary human hepatocyte model of non-alcoholic steatohepatitis. In: JOURNAL OF HEPATOLOGY. 2022. p. S718–S718.
Russell, Matthew, et al. “LIVRQNac increases fatty acid oxidization in a primary human hepatocyte model of non-alcoholic steatohepatitis.” JOURNAL OF HEPATOLOGY, vol. 77, 2022, pp. S718–S718.
Russell M, Newgard C, Zhang G, Nitzel A, Hamill M, Azer K. LIVRQNac increases fatty acid oxidization in a primary human hepatocyte model of non-alcoholic steatohepatitis. JOURNAL OF HEPATOLOGY. 2022. p. S718–S718.
Published In
JOURNAL OF HEPATOLOGY
EISSN
1600-0641
ISSN
0168-8278
Publication Date
2022
Volume
77
Start / End Page
S718 / S718
Related Subject Headings
- Gastroenterology & Hepatology
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1103 Clinical Sciences